Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Japan
Summary - A: Lenalidomide Hydrate 5 Mg X 40 Capsules/Box 500 Boxes, B: Labrizumab (Genetic Recombination) Injection Solution 300 Mg 3 Ml/Bottle 900 Bottles, C: Labrizumab (Genetic Recombination) Injection Solution 1,100 Mg 11 Ml/Bottle 120 Bottles, D: Butoliciranna.
Deadline - Jul 01, 2025
GT reference number - 111087878
Product classification - Medical equipments, pharmaceuticals and personal care products
Address - Japan
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 111087878
Document Type - Tender Notices
Description - Description: Bid announcementGeneral competitive bids are included as follows:June 16th, 2025Kumamoto University National University CorporationContract manager, Kuronuma Ichiro◎Procurement agency number: 415 ◎Location number: 43○No. 81. Procur ement details⑴ Item classification number 4⑵ Purchasing subject and quantityA Lenalidomide Hydrate 5mg x 40 capsules/box 500 boxesB: Labrizumab (Genetic Recombinant) Injection Solution 300mg 3mL/Bonus 900 bottlesC: Labrizumab (Genetic Recombinant) Injection Solution 1,100mg 11mL/Bonus 120 bottlesD Butolisilane Sodium Kit 25mg 0.5mL x 1 tube/box 140 boxesE: Rinevilizumab (Genetic Recombinant) Injection 100mg 10mL/Bonus 6 bottlesF Onasemnogen A
Gt Ref Id - 111087878
Deadline - Jul 01, 2025
Similar Tenders :
Summary:
|
Summary:
|
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database